Deswell Industries, Inc. (NASDAQ:DSWL – Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 4,210 shares, an increase of 89.8% from the April 30th total of 2,218 shares. Based on an average daily trading volume, of 8,300 shares, the short-interest ratio is currently 0.5 days. Approximately 0.0% of the company’s shares are short sold.
Deswell Industries Trading Down 2.4%
Deswell Industries stock opened at $3.27 on Tuesday. The firm has a 50-day moving average of $3.28 and a 200-day moving average of $3.42. The firm has a market cap of $52.12 million, a P/E ratio of 6.81 and a beta of 0.66. Deswell Industries has a 1-year low of $2.26 and a 1-year high of $4.48.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings lowered shares of Deswell Industries from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, May 18th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold”.
Institutional Trading of Deswell Industries
A hedge fund recently bought a new stake in Deswell Industries stock. Royal Palms Capital LLC acquired a new position in Deswell Industries, Inc. (NASDAQ:DSWL – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 460,893 shares of the technology company’s stock, valued at approximately $1,595,000. Deswell Industries accounts for 1.9% of Royal Palms Capital LLC’s holdings, making the stock its 24th largest holding. Royal Palms Capital LLC owned 2.89% of Deswell Industries at the end of the most recent reporting period.
About Deswell Industries
Deswell Industries, Inc (NASDAQ: DSWL) is a China-based medical device company that designs, develops, manufactures and distributes airway management and respiratory care products. The company’s product portfolio includes laryngeal mask airways, disposable endotracheal tubes, nebulizers, oxygen therapy equipment, humidifiers and related ventilator accessories. Deswell’s devices are used in hospitals, clinics and home-care settings to support anesthesia, emergency medicine and respiratory treatment.
Founded in 2003 and headquartered in Shenzhen, Deswell operates multiple manufacturing facilities that comply with international quality standards, including FDA 510(k) clearances and CE markings for many of its devices.
Featured Stories
- Five stocks we like better than Deswell Industries
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Deswell Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deswell Industries and related companies with MarketBeat.com's FREE daily email newsletter.
